A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma

NCT02230917 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Sotatercept
DRUG: Placebo

Sponsor

Rebecca Silbermann

Collaborators

[object Object]